Reuters - Video

Edition: US | UK | IN | CN | JP

video Finance Videos

Breakingviews TV: Drug wars

Thursday, September 06, 2018 - 04:17

Antony Currie and Robert Cyran explain why regulatory fiat and a nonprofit competitor set up by disgruntled U.S. hospitals are making life hard for makers of generic medicine. That’s why Novartis is selling its unit on the cheap – and why other such deals may follow.

▲ Hide Transcript

View Transcript

Antony Currie and Robert Cyran explain why regulatory fiat and a nonprofit competitor set up by disgruntled U.S. hospitals are making life hard for makers of generic medicine. That’s why Novartis is selling its unit on the cheap – and why other such deals may follow.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Breakingviews TV: Drug wars

Thursday, September 06, 2018 - 04:17